Prevention of Cardiac Hypertrophy by Atorvastatin in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy

Cardiac hypertrophy, a major determinant of morbidity and mortality in hypertrophic cardiomyopathy (HCM), is considered a secondary phenotype and potentially preventable. To test this hypothesis, we screened 30 5- to 6-month-old β-myosin heavy chain Q403 transgenic rabbits by echocardiography and se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Senthil, Vinitha, Chen, Suet N., Tsybouleva, Natalie, Halder, Tripti, Nagueh, Sherif F., Willerson, James T., Roberts, Robert, Marian, A.J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2005
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1201449/
https://ncbi.nlm.nih.gov/pubmed/16020756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/01.RES.0000177090.07296.ac
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge